Damsa Pharma Private Limited
About Damsa Pharma Private Limited
Data last updated:
Damsa Pharma Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2020PTC085559. Its GSTIN is 06AAHCD6837C1ZR (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veena Pratap and Satish Kumar Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kuldeep Nagar Nanhera Road, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.47 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹80,200 (net margin -3.9%) and EBITDA of -₹16,500 (EBITDA margin -0.8%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKuldeep Nagar Nanhera Road, Ambala Cantt, Haryana, India – 133001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Damsa Pharma Private Limited
The main business activity of Damsa Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Damsa Pharma Private Limited FY 2025 filings available
Damsa Pharma Private Limited reported revenue of ₹20.47 Lakh (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Damsa Pharma Private Limited
Revenue fell 21% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 119% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Damsa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹16,500 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹80,200 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Damsa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Damsa Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Damsa Pharma Private Limited
Damsa Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mad Asn Pharma Private Limited | ₹20.67 Lakh (FY 2023) | •••• | •••• | -22.0% | •••• | Sambhal, Uttar Pradesh, India |
| Purpozo Brands Private Limited | ₹20.64 Lakh (FY 2025) | •••• | •••• | 137501.0% | •••• | Ahmedabad, Gujarat, India |
| MMG Pharmaceuticals Private Limited | ₹20.57 Lakh (FY 2021) | •••• | •••• | 67.0% | •••• | New Delhi, Delhi, India |
| Raptron Lifesciences Private Limited | ₹20.57 Lakh (FY 2025) | •••• | •••• | 94.0% | •••• | Bhopal, Madhya Pradesh, India |
| Arcon Pharmaceuticals Private Limited | ₹20.48 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Patna, Bihar, India |
| Damsa Pharma Private Limited this company | ₹20.47 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Ambala Cantt, Haryana, India |
| Cmyk Health Products Private Limited | ₹20.4 Lakh (FY 2023) | •••• | •••• | -65.0% | •••• | Thane, Maharashtra, India |
| Madsway Solutions Private Limited | ₹20.37 Lakh (FY 2021) | •••• | •••• | 445.0% | •••• | India, Delhi |
| Inqure Health Trading Private Limited | ₹20.33 Lakh (FY 2024) | •••• | •••• | -77.0% | •••• | Gurgaon, Haryana, India |
| Data Gram Consultancy Services Private Limited | ₹20.3 Lakh (FY 2025) | •••• | •••• | 420.0% | •••• | New Delhi, Delhi, India |
| Chandra Paramedical Education Private Limited | ₹20.2 Lakh (FY 2025) | •••• | •••• | 186.0% | •••• | Motihari, Bihar, India |
Peers are the five companies nearest above and the five nearest below Damsa Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Damsa Pharma Private Limited
Damsa Pharma Private Limited is audited by VIJAY GUPTA & JAIN for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIJAY GUPTA & JAIN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Damsa Pharma Private Limited
Damsa Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Pratap Also directs: Alvid Biocare LLP, Ani Healthcare Private Limited | Director | 21 Feb 2020 | 6 Years 7 Months | Current |
| Satish Kumar Kapoor | Director | 17 Aug 2024 | 2 Years 1 Months | Current |
Ownership and Shareholding of Damsa Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Damsa Pharma Private Limited
Damsa Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Damsa Pharma Private Limited
Employment history and EPFO contributions of people linked to Damsa Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Damsa Pharma Private Limited
Damsa Pharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Sangeeta ceased to be Director on 22 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Damsa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Damsa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Damsa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Damsa Pharma Private Limited
Damsa Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCD6837C1ZR | Haryana | Active | 29 Jul 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Damsa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Damsa Pharma Private Limited
Damsa Pharma is an active private limited company based in Ambala Cantt, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 February 2020 (6+ years old) and is registered under CIN U24290HR2020PTC085559.
Damsa Pharma reported revenue of ₹20.47 Lakh for FY 2025 (down 21% YoY).
Damsa Pharma has 2 current directors:
- Veena Pratap - Director
- Satish Kumar Kapoor - Director
Damsa Pharma reported a net loss of ₹80,200 (net margin -3.9%) and EBITDA of -₹16,500 (EBITDA margin -0.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Damsa Pharma is 21% over three years. In the latest year (FY 2025) revenue fell 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Damsa Pharma is 06AAHCD6837C1ZR, registered in Haryana.
The CIN (Corporate Identification Number) of Damsa Pharma is U24290HR2020PTC085559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Damsa Pharma was incorporated on 21 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Damsa Pharma by revenue are Mad Asn Pharma Private Limited, Purpozo Brands Private Limited, MMG Pharmaceuticals Private Limited, Raptron Lifesciences Private Limited, Arcon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Sangeeta ceased to be Director on 22 Aug 2024. Satish Kumar Kapoor was appointed as Director on 17 Aug 2024. Veena Pratap was appointed as Director on 21 Feb 2020.
The registered office of Damsa Pharma is at Kuldeep Nagar Nanhera Road, Ambala Cantt, Haryana, India – 133001.